UK Markets open in 5 hrs 13 mins

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
132.27+2.91 (+2.25%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3212.00
52-week low 3117.58
50-day moving average 3150.56
200-day moving average 3169.60

Share statistics

Avg vol (3-month) 3855.67k
Avg vol (10-day) 3841.64k
Shares outstanding 5119.6M
Implied shares outstanding 6N/A
Float 8120.08M
% held by insiders 10.62%
% held by institutions 194.18%
Shares short (28 Apr 2022) 45.92M
Short ratio (28 Apr 2022) 46.57
Short % of float (28 Apr 2022) 45.77%
Short % of shares outstanding (28 Apr 2022) 44.90%
Shares short (prior month 30 Mar 2022) 45.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -101.46%
Operating margin (ttm)-76.04%

Management effectiveness

Return on assets (ttm)-12.51%
Return on equity (ttm)-134.53%

Income statement

Revenue (ttm)879.98M
Revenue per share (ttm)7.38
Quarterly revenue growth (yoy)20.10%
Gross profit (ttm)704.14M
EBITDA -624.7M
Net income avi to common (ttm)-892.87M
Diluted EPS (ttm)-7.13
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.24B
Total cash per share (mrq)18.54
Total debt (mrq)995.39M
Total debt/equity (mrq)248.12
Current ratio (mrq)4.27
Book value per share (mrq)6.33

Cash flow statement

Operating cash flow (ttm)-577.23M
Levered free cash flow (ttm)154.33M